openPR Logo
Press release

What's driving the Glaucoma Treatment Market Size Key Players are: Allergan, Pfizer, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Teva Pharmaceuticals

06-13-2019 07:49 PM CET | Industry, Real Estate & Construction

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
What's driving the Glaucoma Treatment Market Size Key Players

An analysis of Glaucoma Treatment market has been provided in the latest report added by Market Study Report that primarily focuses on the market trends, demand spectrum, and future prospects of this industry over the forecast period. Furthermore, the report provides a detailed statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders.

The report titled Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors) has covered and analyzed the potential of Global Glaucoma Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global glaucoma treatment. Additionally, the report also highlights market entry strategies for various companies across the globe.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1357062/?utm_source=open&utm_medium=Deepak

Company Analysis Allergan, Pfizer, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Teva Pharmaceuticals.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Glaucoma Treatment Market. The report analyzes the global glaucoma treatment market By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others) and By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Others). The report analyzes the global glaucoma treatment market By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S., Canada, U.K, Germany, India, China, Japan and Brazil). The report assesses the glaucoma treatment market for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to research report Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors) , global glaucoma treatment market is projected to display a robust growth represented by a CAGR of 4.81 % during 2018 2023.

The segment of Prostaglandin Analogs witnessed growth at a noteworthy rate over the past few years backed by increased prevalence of glaucoma, easy availability of dug along with rising number of hospitals and their respective pharmacies. Amongst the regions, North America accounts for the largest regional share in the global glaucoma treatment market in 2018. Key factors driving the robust growth rate of North America region include Well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of glaucoma in the region.

Scope of the Report

Global Glaucoma Treatment Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
Global Glaucoma Treatment Market Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others
By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
By Sales Channel Hospital Pharmacy, Retail Pharmacy, Others

Regional Markets North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Glaucoma Treatment Market Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
By Sales Channel Hospital Pharmacy, Retail Pharmacy, Others

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Glaucoma Treatment Market Size, Growth, Forecast
By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
By Sales Channel Hospital Pharmacy, Retail Pharmacy, Others

Other Report Highlights
Market Dynamics Drivers and Restraints
Market Trends
Porter Five Force Analysis
Policy and Regulatory Landscape
Competitive Landscape

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1357062/?utm_source=open&utm_medium=Deepak

Customization of the Report
The report could be customized according to the client s specific research requirements. No additional cost will be required to pay for limited additional research.

Table of content

1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Glaucoma Treatment Market Overview
5. Global Glaucoma Treatment: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. Global Glaucoma Treatment Market: Analysis By Indication
6.1 Global Glaucoma Treatment Market-By Indication: Breakdown(%)
6.1.1 Global Glaucoma Treatment Market Size and Share, By Indication, 2017
6.1.2 Global Glaucoma Treatment Market Size and Share, By Indication, 2023
6.2 Global Open Angle Glaucoma Treatment Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Closed Angle Glaucoma Treatment Market Overview
6.3.1 By Value (2013-2023)
6.4 Global Secondary Glaucoma Treatment Market Overview
6.4.1 By Value (2013-2023)
6.5 Global Congenital Glaucoma Treatment Market Overview
6.5.1 By Value (2013-2023)
6.6 Global Others Glaucoma Treatment Market Overview
6.6.1 By Value (2013-2023)
7. Global Glaucoma Treatment Market: Analysis By Drug Class
7.1 Global Glaucoma Treatment Market: By Drug Class: Breakdown(%)
7.1.1 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class, 2017
7.1.2 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class ,2023
7.2 Global Prostaglandin Analogs Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
7.2 Global Beta Blockers Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
7.3 Global Alpha Agonist Glaucoma Treatment Market Overview
7.3.1 By Value (2013-2023)
7.4 Global Carbonic Anhydrase Inhibitors Glaucoma Treatment Market Overview
7.4.1 By Value (2013-2023)
7.5 Global Others Glaucoma Treatment Market Overview
7.5.1 By Value (2013-2023)
8. Global Glaucoma Treatment: Sales Channel Analysis
8.1 Global Glaucoma Treatment Market-By Sales Channel : Breakdown(%)
8.1.1 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2017
8.1.2 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2023
8.2 Global Hospital Pharmacy Glaucoma Treatment Market Overview
8.2.1 By Value (2013-2023)
8.3 Global Retail Pharmacy Glaucoma Treatment Market Overview
8.3.1 By Value (2013-2023)
8.4 Global Others Glaucoma Treatment Market Overview
8.4.1 By Value (2013-2023)
9. Global Glaucoma Treatment Market: Regional Analysis

More Details on this Report: https://www.marketstudyreport.com/reports/global-glaucoma-treatment-market-analysis-by-indication-by-drug-class-by-sales-channel-by-region-by-country-2018-edition-forecast-to-2023-by-indication-open-angle-closed-angle-secondary-congenital-others-by-drug-class-prostaglandin-analogs-beta-blockers-alpha-agonist-carbonic-anhydrase-inhibitors

Contact Us:

Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Glaucoma Treatment Market Size Key Players are: Allergan, Pfizer, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Teva Pharmaceuticals here

News-ID: 1774978 • Views:

More Releases from marketstudyreport.com

Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Power Technologies (Schneider Electric), Simplex, Shenzhen Sikes, Pite Tech
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders. Load Bank Market Size was estimated
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - John Deere, CNH Industrial, Kubota, AGCO, Claas, Yanmar, Mahindra, LOVOL
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc., Volkswagen AG, SAIC Motors, BYD Auto Co. Ltd., BMW Group, Nissan Motor Co. Ltd., Hyundai Group
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028. The operation is done to stop ligament tears and
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - Garrett Motion, Hanon Systems, UQM Technologies, FISCHER Fuel Cell Compressor
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting

All 5 Releases


More Releases for Glaucoma

Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Market Spotlight: Glaucoma
Boston, MA ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports. Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid
North America Glaucoma Therapeutics Market grows with growing awareness regardin …
Glaucoma Therapeutics Market: Scope and Methodology The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the major glaucoma therapeutics market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study
Glaucoma Treatment Market : Rising Geriatric Population And Healthcare Expenditu …
Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and